Novartis is set to launch its one-off gene ... process (AMNOG) in Germany and this will be ongoing in the coming months, potentially making Germany one of the first countries to make gene ...

Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes.

Your body remembers what your mind forgets. Discover how trauma lives in your cells and the breakthrough therapies that can ...

This new review article published in Genes & Diseases sheds light on the pivotal role of fatty acid oxidation (FAO) in the ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

Researchers isolated one kind of cone in the eye and aimed lasers at it to allow subjects to see a super vibrant teal shade ...

Reza Zafarqandi and his Indian and Uzbek counterparts have explored the potential for the expansion of health cooperation, ...

A comprehensive guide to Ponant cruise ships, itineraries, cabins, onboard restaurants, entertainment, policies and more.

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...

April 29 (Reuters) - The U.S. Food and Drug Administration approved Abeona Therapeutics' (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn ...

Oral and poster presentations will highlight advancements from ElevateBio's two business units: Life Edit, its gene editing and R&D ... vector manufacturing platform process, LentiPeak, developed for ...